BioSpace News Archive

Contract with second IPA serving California expands patient access to Biocept’s Target Selector™ liquid biopsy testing for the management of patients diagnosed with cancer [26-March-2020] SAN DIEGO , March 26, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actio

Incyte announces the appointment of Katherine High, M.D., as a new member of the Board of Directors, effective March 25, 2020.

Decibel Therapeutics , today announced that Phase 1a trial results demonstrating the safety and tolerability of its lead candidate, DB-020, have been published in the peer-reviewed journal Investigational New Drugs . DB-020 is being developed for the prevention of cisplatin-induced hearing loss. The

March 26, 2020 12:00 UTC ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing - New company formed from combination of TranscripTx and ReCode Therapeutics - Advancing mRNA-mediated protein replacement and tRNA NanoCorrector therapies for primary ciliary dyskinesia and cystic fibrosis - Developing proprietary non-viral lipid nanoparticle delivery platform for organ-specific delivery of RNA therapies and gene editing components MENLO PARK,

Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), announces that its global intellectual property portfolio has increased to 49 issued patents and 86 patent applications, including the recent granting and filing of patent applications directed at innovative robotic surgery technologies.

ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq: ANIP) today announced the launch of Polyethylene Glycol 3350, 17g/Packet (PEG-3350). The current annual market for this over the counter (OTC) product is approximately $21 million , according to IQVIA. This launch represents ANI’s fourth new drug introduction in 2020. About Polyethy

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Omar Manejwala, M.D to the newly created position of Chief Medical Officer, and Barbara Stark as Senior Vice President and Head of Managed Markets.

Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it is launching a hand sanitizer to h

Today Harvest Health & Recreation Inc. (CSE: HARV, OTCQX:HRVSF) (“Harvest”) and Verano Holdings, LLC (“Verano”) announced the mutual termination of the Business Combination Agreement dated April 22, 2019 (the “BCA”).

- VGX-3100 DNA medicine cleared high-risk HPV 16/18-associated precancerous lesions in 50% of patients, and reduced the number of lesions in 75% of patients - Data to be presented at the 2020 American Society for Colposcopy and Cervical Pathology (ASCCP) meeting [26-March-2020] PLYMOUTH MEETING, Pa. , March 26, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, In